Body Composition
Body composition assessment goes beyond BMI with growing evidence-based methods. The session covers DXA body composition as the clinical reference standard, BIA in clinical practice and its limitations, MRI-based body composition for research, visceral vs subcutaneous fat differential effects, ectopic fat accumulation patterns, and the GLP-1 era preservation-of-lean-mass focus. Discussion addresses bioimpedance in fluid shifts, ASM/BMI ratio for sarcopenic obesity, waist circumference as a clinical proxy, the role of body composition in cardiometabolic risk beyond BMI, and emerging methods including air-displacement plethysmography (Bod Pod), DEXA, and quantitative MRI.
- DXA reference standard
- BIA clinical limitations
- MRI body composition
- Visceral vs subcutaneous fat
- ASM/BMI ratio
- Waist circumference
- Bod Pod air-displacement
- Quantitative MRI
Explore the full GSOD 2027 program
- 01GLP-1 & Incretin Therapies
- 02Bariatric Surgery
- 03Childhood & Adolescent Obesity
- 04Obesity Genetics & Epigenetics
- 05Metabolic Syndrome
- 06Behavioral & Lifestyle Interventions
- 07Gut Microbiome & Metabolism
- 08Health Equity in Obesity Care
- 09Policy, Environment & Prevention
- 10Weight Loss Maintenance
- 11Eating Disorders & Obesity
- 12Sarcopenic Obesity
- 13Hormonal Drivers
- 14Cardiometabolic Complications
- 15MASH & Obesity-Liver Axis
- 16Sleep & Obesity
- 17Workplace & School Programs
- 18Pharmacotherapy Pipeline
- 19Type 1 Diabetes
- 20Type 2 Diabetes
- 21Diabetic Retinopathy
- 22Diabetic Neuropathy
- 23Diabetic Kidney Disease
- 24Polycystic Ovary Syndrome
- 25Thyroid & Weight
- 26Insulin Resistance
- 27Lipid Metabolism
- 29Body Image & Mental Health
- 30Diabetes in Pregnancy
- 31Telemedicine in Obesity
- 32Endocrine Disruptors
- 33Health Coaching
- 34Geriatric Obesity
- 35Stigma & Communication